Is Selectivity the JAKpot Winner for Inflammatory Bowel Disease Treatment?

Affiliations

¹ Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University, Milan, Italy, and, Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
² Department of Gastroenterology, University of Lorraine, CHRU-Nancy, Nancy, France, and, University of Lorraine, Inserm, NGERE, Nancy, France.
³ Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University, Milan, Italy. Electronic address: sdanese@hotmail.com.

Editorial

Ferdinando D'Amico et al. Gastroenterology. 2022 Dec.

. 2022 Dec;163(6):1482-1484.

doi: 10.1053/j.gastro.2022.09.011. Epub 2022 Sep 22.

¹ Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University, Milan, Italy, and, Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
² Department of Gastroenterology, University of Lorraine, CHRU-Nancy, Nancy, France, and, University of Lorraine, Inserm, NGERE, Nancy, France.
³ Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University, Milan, Italy. Electronic address: sdanese@hotmail.com.

No abstract available

Comment on

Efficacy and Safety of Ivarmacitinib in Patients With Moderate-to-Severe, Active, Ulcerative Colitis: A Phase II Study.
Chen B, Zhong J, Li X, Pan F, Ding Y, Zhang Y, Chen H, Liu F, Zhang Z, Zhang L, Drozda R, Oliinyk O, Goh AH, Chen X, Sun X, Rubin DT, Sandborn WJ, Chen M. Chen B, et al. Gastroenterology. 2022 Dec;163(6):1555-1568. doi: 10.1053/j.gastro.2022.08.007. Epub 2022 Aug 10. Gastroenterology. 2022. PMID: 35963369 Clinical Trial.